Spdr S&p Pharmaceuticals Etf ETF Forecast

Buy or Hold candidate since Jun 09, 2026 Gain 8.44%

The SPDR S&P Pharmaceuticals ETF price gained 1.77% on the last trading day (Tuesday, 23rd Jun 2026), rising from $62.11 to $63.21. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the ETF fluctuated 3.43% from a day low at $61.75 to a day high of $63.87. The price has risen in 9 of the last 10 days and is up by 10.72% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 76 thousand more shares were traded than the day before. In total, 189 thousand shares were bought and sold for approximately $11.94 million.

The ETF lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $63.62 will firstly indicate a stronger rate of rising. Given the current short-term trend, the ETF is expected to rise 9.77% during the next 3 months and, with a 90% probability hold a price between $62.55 and $69.84 at the end of this 3-month period.

XPH Signals & Forecast

The SPDR S&P Pharmaceuticals ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $61.11 and $58.65. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 13.48%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. The ETF had a Golden Star Signal on Tuesday, July 08, 2025 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.

Support, Risk & Stop-loss for SPDR S&P Pharmaceuticals ETF

On the downside, the ETF finds support just below today's level from accumulated volume at $56.61 and $55.81. There is a natural risk involved when a ETF is testing a support level, since if this is broken, the ETF then may fall to the next support level. In this case, SPDR S&P Pharmaceuticals finds support just below today's level at $56.61. If this is broken, then the next support from accumulated volume will be at $55.81 and $55.70.

This ETF has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the ETF moved $2.12 between high and low, or 3.43%. For the last week, the ETF has had daily average volatility of 1.99%.

The SPDR S&P Pharmaceuticals ETF is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some ETFS may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the ETF manages to break the trend before that occurs.

Our recommended stop-loss: $60.95 (-3.58%) (This ETF has medium daily movements and this gives medium risk. The RSI14 is 90 and this increases the risk substantially. There is a buy signal from a pivot bottom found 14 days ago.)

Trading Expectations (XPH) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect SPDR S&P Pharmaceuticals ETF to open at $62.94, and during the day (based on 14 day Average True Range), to move between $62.59 and $63.83, which gives a possible trading interval of +/-$1.23 (+/-1.97%) up or down from last closing price. If SPDR S&P Pharmaceuticals ETF takes out the full calculated possible swing range there will be an estimated 1.97% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $56.61, some $6.60 (10.44%) from the current price of $63.21, our system finds the risk reward attractive.

Is SPDR S&P Pharmaceuticals ETF ETF A Buy?

SPDR S&P Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $62.94 ( 0.422%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk